ArticleFrontiers in cellular and infection microbiology2026
Exosomes in cerebrospinal fluid as biomarkers of bacterial infections of the central nervous system: a pilot study.
Article in Frontiers in cellular and infection microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Exosome-derived LncRNAs in bone remodeling: recent advances and future directions for bone disease therapy.Stem cell research & therapy · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Intracranial infections present a significant diagnostic challenge. This pilot study aimed to evaluate the potential of cerebrospinal fluid (CSF)-derived exosomes as novel diagnostic biomarkers for bacterial central nervous system infections. Methods: We enrolled nine patients from Changsha Central Hospital, forming three groups: culture-confirmed intracranial infection (n=3), cerebral hemorrhage with bloody CSF (n=3), and cerebral hemorrhage with clear CSF (n=3). Exosomes were isolated from CSF via ultracentrifugation and characterized using transmission electron microscopy and nanoparticle tracking analysis to assess morphology, concentration, and particle size. Statistical differences between groups were analyzed. Results: Exosomes were successfully detected in all but one clear-CSF patient. The infected CSF group exhibited a significantly higher mean exosome concentration (1.37e+11 ± 4.40e+10 particles/ml) compared to the bloody (4.08e+9 ± 1.95e+9 particles/ml) and clear CSF groups (1.10e+9 ± 0.56e+9 particles/ml; both p<0.001). Exosome diameter was also significantly larger in infected CSF (167.78 ± 18.65 nm) than in bloody (146.63 ± 6.92 nm) and clear CSF (123.77 ± 13.68 nm; both p<0.001). Conclusions: This study demonstrates that both the concentration and size of CSF exosomes are significantly elevated in patients with intracranial infections. These findings suggest CSF exosomes hold promise as valuable diagnostic biomarkers, though validation in larger cohorts is necessary to confirm their clinical utility.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.